The Wall Street Transcript1 天
Seeking Stability and Growth in Volatile Emerging Markets
Could you tell us about the firm and your role there? Mr. Khuller: I’m the Vice President and Portfolio Manager at Letko Brosseau in Montreal, Canada. We manage about CAD18 billion in assets for our ...
The Wall Street Transcript1 天
Paul Jarman – Ucn, Inc. (ucnn)
The Wall Street Transcript is a completely unique resource for investors and business researchers.
The Wall Street Transcript1 天
Royalty Pharma plc
The Wall Street Transcript is a completely unique resource for investors and business researchers.
The Wall Street Transcript1 天
IN8bio, Inc.
The Wall Street Transcript is a completely unique resource for investors and business researchers.
The Wall Street Transcript1 天
Neuren Pharmaceuticals Ltd.
The Wall Street Transcript is a completely unique resource for investors and business researchers.
The Wall Street Transcript1 天
Praxis Precision Medicines Inc.
The Wall Street Transcript is a completely unique resource for investors and business researchers.
The Wall Street Transcript1 天
Lexaria Bioscience Corp.
The Wall Street Transcript is a completely unique resource for investors and business researchers.
The Wall Street Transcript1 天
60 Degrees Pharmaceuticals, Inc.
The Wall Street Transcript is a completely unique resource for investors and business researchers.
The Wall Street Transcript2 天
OSE Immunotherapeutics SA (EPA:OSE): This Publicly Traded French Company has a Vaccine for ...
Interview with Nicolas Poirier, CEO at OSE Immunotherapeutics a biotech with a compound that is a therapeutic cancer vaccine, ...
The Wall Street Transcript2 天
Interview with the CEO: OSE Immunotherapeutics SA (EPA:OSE)
Can you tell me about the company? Mr. Poirier: Sure. OSE Immunotherapeutics is a French biotech — the company is listed on Euronext Paris — and we are developing immunotherapies. Specifically, these ...